In late May, BDR had sought the approval of India's drug regulator to
make and sell remdesivir in India without entering into an arrangement
with Gilead. The Mumbai-based company has now signed a contract to
make the drug for Cipla, which is one of the licensed companies.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bdr-in-pact-to-make-gilead-drug-for-cipla/articleshow/76127236.cms
No comments:
Post a Comment